Implantable Insulin Pump Market Size, Share, and Trends Analysis Report

CAGR :  Diagram

Market Size 2023 (Base Year) USD 2.32 Billion
Market Size 2032 (Forecast Year) USD 4.56 Billion
CAGR 7.8%
Forecast Period 2024 - 2032
Historical Period 2018 - 2023

Implantable Insulin Pump Market Insights

As per the published report by Market Research Store, the global Implantable Insulin Pump Market size was estimated at USD 2.32 Billion in 2023 and is anticipated to reach USD 4.56 Billion by 2032, growing at a projected CAGR of 7.8%. The report provides a detailed analysis of the global market, including market trends, market dynamics, and market opportunities during the forecast period (2024-2032). It delves deeper into several market facets, such as market definition, size, growth, forecast, segmentation, competitive analysis, growth drivers, restraints, financial analysis, SWOT analysis, PORTER’s five force analysis, PESTEL analysis, market share analysis, cost-benefit analysis, challenges, restraints, strategic recommendations, and market players.

Implantable Insulin Pump Market Size

To Get more Insights, Request a Free Sample



Global Implantable Insulin Pump Market: Overview

The implantable insulin pump is surgically entrenched under the skin, while a catheter from the pump extends to the peritoneal cavity. The critical difference between eternal and implantable insulin pump is that the insulin delivered to the peritoneal cavity is quickly routed to the liver. Through the implantable insulin pump, the liver receives a high concentration of insulin, keeps a large percentage of it and permits only a small amount to pass to the rest of the body.

One of the prominent contributors includes the increasing awareness about the advantages of implantable insulin pumps created by industry experts. For instance, the Implantable Insulin Pump Foundation works actively to encourage and assist the progress of improved and technologically modern implantable insulin pumps, so that the patient receives a remarkable diabetes management solution.

The underlying diseases of the patient can cause complications and need to be monitored & treated with an utmost essentiality. For instance, congestive heart failure affects 3 to 4 million people in the US. This condition is responsible for nearly 30,000 to 40,000 deaths annually in the country. Thus, drug therapies are not hundred percent effective in such cases, and the need for innovative pumps emerge.

Implantable insulin pump Market

To Get more Insights, Request a Free Sample

Global Implantable Insulin Pump Market: Factors

The global implantable insulin pump market growth is rising at a tremendous pace owing to the factors such as the rising diabetic population, rapid urbanization in most developing as well as underdeveloped regions, and the inclination of key players towards creating awareness on the essentiality of implantable insulin pumps.

The COVID-19 outbreak has disrupted the implantable insulin pump industry during the previous year. Owing to the several restrictions on movement levied by the government all throughout the world, there was a halt in the surgeries performed. Although this situation was for a limited period, the urgent patients received the essential care. With the adoption of alternative approaches of telehealth and COVID risk scheduling techniques in hospitals, the market is set to grow amid the pandemic.

Global Implantable Insulin Pump Market: Segmentation

The global implantable insulin pump market is classified based on type, disease, end user, and region.

Based on the type, the global implantable insulin pump market is segmented into closed-loop insulin pump and open-loop insulin pump.

On the basis of disease, the global implantable insulin pump market is bifurcated into type 1 diabetes and type 2 diabetes.

Based on end user, the market is segmented into hospitals and home care.

Implantable Insulin Pump Market: Report Scope

Report Attributes Report Details
Report Name Implantable Insulin Pump Market
Market Size in 2023 USD 2.32 Billion
Market Forecast in 2032 USD 4.56 Billion
Growth Rate CAGR of 7.8%
Number of Pages 196
Key Companies Covered Diabeloop, Apex Medical, CVS Health (Aetna Inc.), Diamesco Co., Ltd, Insulet Corporation, F. Hoffmann La Roche Ltd, Johnson & Johnson, SOOIL Developments Co. Ltd, Medtronic Plc, and Tandem Diabetes Care, among others
Segments Covered By Disease, By End user and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Implantable Insulin Pump Market: Regional Analysis

The European region is estimated to hold the largest share in the global implantable insulin pump market over the forecast period. The rise in government initiatives, growing concerns regarding insulin administration, diabetes management, & injuries, rise in research activities, and the increase in the number of prominent providers are the key elements driving the growth of the market in this region. For instance, in August 2021, a team of Italian researchers published a study in the Science Robotics journal about a two-component system called PILLSID, which includes an implantable insulin pump that sits in the abdomen area and an ingestible magnetic hormone capsule to refill it. Thus, such promising research directly points towards the significant share of this region in the global implantable insulin pump market.

Moreover, North America is projected to witness considerable growth in the market due to the growing competition among the manufacturers, as well as increasing clinical trials in the field. The rising medical costs as well as the surging patient population pushes the growth of the North American implantable insulin pump market in the anticipated period. For instance, according to the American Diabetes Association, diabetes mellitus affects an approximate of 16 million people in the US. Out of these, nearly ten percent constitute type 1 diabetes, which can only be managed by injections of insulin. Such groups of patients are likely to benefit most directly from the innovative implantable insulin pump technology.

Global Implantable Insulin Pump Market: Competitive Players

Some of the key players in the global implantable insulin pump market are:

  • Diabeloop
  • Apex Medical
  • CVS Health (Aetna Inc.)
  • Diamesco Co., Ltd
  • Insulet Corporation
  • F. Hoffmann La Roche Ltd
  • Johnson & Johnson
  • SOOIL Developments Co. Ltd
  • Medtronic Plc
  • Tandem Diabetes Care
  • among others.

The global Implantable Insulin Pump Market is segmented as follows:  

By Disease

  • closed-loop insulin pump
  • open-loop insulin pump

By End user

  • hospitals
  • home care

Global Implantable Insulin Pump Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Frequently Asked Questions

The market is segmented based on , By Disease (closed-loop insulin pump and open-loop insulin pump), By End user (hospitals and home care) Industry Trends and Forecast to 2032.

Global Implantable Insulin Pump Market to grow from US$ 2.32 Billion in 2023 to US$ 4.56 Billion by 2032

The Global Implantable Insulin Pump Market is projected to grow at a CAGR of 7.8%% during the forecast period of 2023 to 2032.

Diabeloop, Apex Medical, CVS Health (Aetna Inc.), Diamesco Co., Ltd, Insulet Corporation, F. Hoffmann La Roche Ltd, Johnson & Johnson, SOOIL Developments Co. Ltd, Medtronic Plc, and Tandem Diabetes Care, among others

Table Of Content

Inquiry For Buying

Implantable Insulin Pump

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Implantable Insulin Pump

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com